Hong Kong · Delayed Price · Currency is HKD Zai Lab Statistics
Total Valuation
Zai Lab has a market cap or net worth of HKD 23.68 billion. The enterprise value is 21.39 billion.
| Market Cap | 23.68B |
| Enterprise Value | 21.39B |
Important Dates
The last earnings date was Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 1.12B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +3.60% |
| Shares Change (QoQ) | +0.58% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 972.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.83 |
| PB Ratio | 5.36 |
| P/TBV Ratio | 6.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.04, with a Debt / Equity ratio of 0.47.
| Current Ratio | 2.04 |
| Quick Ratio | 1.50 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -45.16 |
Financial Efficiency
Return on equity (ROE) is -29.99% and return on invested capital (ROIC) is -19.22%.
| Return on Equity (ROE) | -29.99% |
| Return on Assets (ROA) | -15.93% |
| Return on Invested Capital (ROIC) | -19.22% |
| Return on Capital Employed (ROCE) | -46.40% |
| Weighted Average Cost of Capital (WACC) | 7.69% |
| Revenue Per Employee | 1.94M |
| Profits Per Employee | -872,599 |
| Employee Count | 1,784 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 5.76 |
Taxes
| Income Tax | -34.38M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.03% in the last 52 weeks. The beta is 0.72, so Zai Lab's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | +24.03% |
| 50-Day Moving Average | 19.33 |
| 200-Day Moving Average | 16.40 |
| Relative Strength Index (RSI) | 65.12 |
| Average Volume (20 Days) | 4,755,793 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 8.04 |
Income Statement
In the last 12 months, Zai Lab had revenue of HKD 3.47 billion and -1.56 billion in losses. Loss per share was -1.40.
| Revenue | 3.47B |
| Gross Profit | 21.92M |
| Operating Income | -2.18B |
| Pretax Income | -1.59B |
| Net Income | -1.56B |
| EBITDA | -2.05B |
| EBIT | -2.18B |
| Loss Per Share | -1.40 |
Balance Sheet
The company has 4.39 billion in cash and 2.10 billion in debt, with a net cash position of 2.29 billion.
| Cash & Cash Equivalents | 4.39B |
| Total Debt | 2.10B |
| Net Cash | 2.29B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.42B |
| Book Value Per Share | 3.93 |
| Working Capital | 3.45B |
Cash Flow
In the last 12 months, operating cash flow was -1.25 billion and capital expenditures -32.39 million, giving a free cash flow of -1.28 billion.
| Operating Cash Flow | -1.25B |
| Capital Expenditures | -32.39M |
| Depreciation & Amortization | 128.99M |
| Net Borrowing | 296.67M |
| Free Cash Flow | -1.28B |
| FCF Per Share | n/a |
Margins
Gross margin is 0.63%, with operating and profit margins of -62.99% and -44.91%.
| Gross Margin | 0.63% |
| Operating Margin | -62.99% |
| Pretax Margin | -45.90% |
| Profit Margin | -44.91% |
| EBITDA Margin | -59.27% |
| EBIT Margin | -62.99% |
| FCF Margin | n/a |
Dividends & Yields
Zai Lab does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.60% |
| Shareholder Yield | -3.60% |
| Earnings Yield | -6.50% |
| FCF Yield | -5.41% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Analyst Forecast
The average price target for Zai Lab is 21.03, which is -2.09% lower than the current price. The consensus rating is "Buy".
| Price Target | 21.03 |
| Price Target Difference | -2.09% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 15.61% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on March 30, 2022. It was a forward split with a ratio of 10.
| Last Split Date | Mar 30, 2022 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
Zai Lab has an Altman Z-Score of -0.65 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.65 |
| Piotroski F-Score | 1 |